Deborah L Hodge

Deborah L Hodge

UNVERIFIED PROFILE

Are you Deborah L Hodge?   Register this Author

Register author
Deborah L Hodge

Deborah L Hodge

Publications by authors named "Deborah L Hodge"

Are you Deborah L Hodge?   Register this Author

22Publications

379Reads

11Profile Views

IL-7-induced phosphorylation of the adaptor Crk-like and other targets.

Cell Signal 2018 07 24;47:131-141. Epub 2018 Mar 24.

Cancer and Inflammation Program, CCR, NCI, NIH, Bldg 560, Frederick, MD 21702, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2018.03.008DOI Listing
July 2018

MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes.

Eur J Immunol 2012 Oct 15;42(10):2644-54. Epub 2012 Aug 15.

Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, Frederick National Laboratory for Cancer Research, NIH, Frederick, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201242408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781587PMC
October 2012

TCR-dependent and -independent activation underlie liver-specific regulation of NKT cells.

J Immunol 2011 Jan 10;186(2):838-47. Epub 2010 Dec 10.

Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1001735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725575PMC
January 2011

Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias.

Cancer Res 2009 May 14;69(9):3986-94. Epub 2009 Apr 14.

Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute-Frederick, and SAIC Frederick, Frederick, Maryland 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-3735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786937PMC
May 2009

Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2.

Mol Cell Biol 2007 Jul 7;27(14):5079-89. Epub 2007 May 7.

Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute-Frederick, Bldg. 560/22-56, 1050 Boyles Street, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.00029-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1951952PMC
July 2007

The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death.

J Interferon Cytokine Res 2006 Oct;26(10):706-18

Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jir.2006.26.706DOI Listing
October 2006

Regulation of ITAM-positive receptors: role of IL-12 and IL-18.

Blood 2006 Feb 25;107(4):1468-75. Epub 2005 Oct 25.

Laboratory of Experimental Immunology and Pediatric Oncology Branch, National Cancer Institute-Center for Cancer Research, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-04-1579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895416PMC
February 2006

Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells.

Blood 2004 Nov 20;104(10):3276-84. Epub 2004 Jul 20.

Laboratory of Experimental Immunology, Center for Cancer Reseach, National Cancer Institute-Frederick, National Institutes of Health, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-02-0664DOI Listing
November 2004

A distal region in the interferon-gamma gene is a site of epigenetic remodeling and transcriptional regulation by interleukin-2.

J Biol Chem 2004 Sep 22;279(39):41249-57. Epub 2004 Jul 22.

Lymphocyte and Cell Biology Section, Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, Maryland 20892-1820, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M401168200DOI Listing
September 2004

Nutritional regulation of mRNA processing.

J Nutr 2004 Sep;134(9):2437S-2443S

Department of Biochemistry and Molecular Pharmacology, School of Medicine, West Virginia University, Morgantown, WV, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jn/134.9.2437SDOI Listing
September 2004

Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation.

Immunity 2004 Jul;21(1):55-66

Laboratory of Experimental Immunology, Center for Cancer Research, National Cancer Institute, National Cancer Institute-Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2004.06.005DOI Listing
July 2004

IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression.

J Immunol 2002 Jun;168(12):6090-8

Laboratories of. Experimental Immunology and Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.168.12.6090DOI Listing
June 2002

Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus.

J Immunol 2002 May;168(10):5163-9

Laboratory of Experimental Immunology, Center for Cancer Research, SAIC-Frederick, National Cancer Institute, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.168.10.5163DOI Listing
May 2002

Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control.

Mol Cell Biol 2002 Mar;22(6):1742-53

Laboratory of Experimental Immunology, National Cancer Institute-Center for Cancer Research, Frederick, MD 21702-1201, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC135596PMC
http://dx.doi.org/10.1128/mcb.22.6.1742-1753.2002DOI Listing
March 2002

Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes.

Eur J Immunol 2002 01;32(1):203-12

Experimental Immunology Branch, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1360, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/1521-4141(200201)32:1<203::AID-IMMU203>3.0.CO;2-CDOI Listing
January 2002